JW Pharmaceutical Corporation (001067.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In KRW
Address
2477, Nambusunhwan-ro
Seoul, 137-864
Korea (the Republic of)
Phone
82 2 840 6777
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1064
First IPO Date
September 29, 2005
| Name | Title | Pay | Year Born |
| Sung-Yeol Lee | Chief Executive Officer, Head of Product Development & Management and Director | 0 | N/A |
| Young-Sub Shin | Chief Executive Officer, Head of Sales & Marketing and Inside Director | 0 | 1963 |
| Jae-Kwang Jeon | Head Managing Director and Head of Public Relation | 0 | 1962 |
| Hyun-seok Han | Head of Product Plant | 0 | 1962 |
| Kim Yong Kwan | Development Head & Internal Director | 0 | N/A |
JW Pharmaceutical Corporation operates as a global entity, actively involved in the creation, production, and distribution of a diverse range of pharmaceuticals and medical provisions. Its market reach extends internationally, with a significant presence in Japan. The company's extensive portfolio encompasses treatments across numerous therapeutic areas, including cardiovascular, gastrointestinal, urinary, and central nervous system health. It also addresses infectious diseases (such as those requiring antibiotics and antifungals), diabetes, obstetric and gynecological conditions, renal disorders, and respiratory ailments. Additionally, their offerings include medications for anemia, rheumatic arthritis, various cancers, anesthesia, antidotes, amino acid formulations, and Total Parenteral Nutrition (TPN). Founded in 1945, JW Pharmaceutical's corporate headquarters are located in Seoul, South Korea.